Cardiosense

Chicago, United States

Cardiosense is a digital biomarker platform that provides multi-sensor devices and proprietary algorithms to detect early signs of diseases.

$15.1M raised

Dec 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cardiosense raised?

Cardiosense has raised $15.1M in total funding. The most recent round was Series A. The last funding was announced in December 2022.

Who are Cardiosense's investors?

Cardiosense's investors include Hatteras Venture Partners, Portal Innovations, OSF Ventures, Laerdal Million Lives Fund, UnityPoint Health Ventures.

Where is Cardiosense headquartered?

Cardiosense is headquartered in Chicago, United States.

What does Cardiosense do?

Cardiosense is a digital biomarker platform that provides multi-sensor devices and proprietary algorithms to detect early signs of diseases.

What stage is Cardiosense at?

Cardiosense is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 8, 2022.

MLA

"Cardiosense — Funding & Investors." VCBacked, December 8, 2022, https://www.vcbacked.co/company/cardiosense. Accessed July 3, 2026.

APA

VCBacked. (2022). Cardiosense — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/cardiosense

Wikipedia (cite web)

{{cite web |title=Cardiosense — Funding & Investors |url=https://www.vcbacked.co/company/cardiosense |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 8, 2022.